Table 2.
Published cardiac MRI findings in post-acute COVID-19
| Study | Number of patients | Mean age (years) | Mean time from COVID-19 diagnosis to MRI (days) | Severity of COVID-19 | Cardiac MRI findings | |||
|---|---|---|---|---|---|---|---|---|
| Total abnormal (%) | Myocarditis-like LGE pattern (%) | Increased T1 values (%) | Increased T2 values (%) | |||||
| Knight et al.52 | 29 | 65 | 37 | Moderate (66%), severe (34%) | 69 | 45 | NR | NR |
| Puntmann et al.53 | 100 | 49 | 71 | Asymptomatic (18%), mild–moderate (49%), severe (33%) | 78 | 32 | 73 | 60 |
| Huang et al.30 | 26 | 38 | 47 | Moderate (85%), severe (15%) | 58 | 31 | NR | 54 |
| Rajpal et al.54 | 26 | 20 | 24 | Asymptomatic (54%), mild (46%) | 46 | 15 | NR | 15 |
| Vago et al.55 | 12 | 23 | 17 | Asymptomatic (17%), mild (83%) | NR | 0 | NR | NR |
| Kotecha et al.56 | 148 | 64 | 68 | Moderate (68%), severe (32%) | 54 | 32 | 13 | 3 |
| Raman et al.57 | 58 | 55 | 70 | Moderate (64%), severe (36%) | NR | 11.5 | ≥26 | ≥3 |
| Małek et al.58 | 26 | 24 | 32 | Asymptomatic (23%), mild (54%), moderate (19%) | 19 | 0 | 0 | 4 |
| Starekova et al.59 | 145 | 20 | 15 | Asymptomatic (17%), mild (49%), moderate (28%), unknown (6%) | ≥29 | 1.4 | NR | NR |
| Clark et al.60 | 59 | 20 | 22 | Asymptomatic (22%), mild (78%) | ≥39 | 3 | NR | NR |
| Martinez et al.61 | 27 | 25 | 19 | Asymptomatic (42%), mild (58%) | ≥19 | 11 | NR | NR |
| Moulson et al.62 | 317 | 20 | 33 | Asymptomatic (33%), mild (29%), moderate (38%) | ≥7 | 5 | NR | NR |
| Pan et al.63 | 21 | 36 | 46 | Mild (19%), moderate (67%), severe (14%) | 71 | NR | 24 | 48 |
| Joy et al.64 | 74 | 37 | 189 | Asymptomatic (15%), mild (84%), moderate (1%) | NR | 4 | 5 | 9 |
| Hendrickson et al.65 | 5 | 20 | 16 | Asymptomatic (18%), mild (55%), moderate (27%) | 0 | 0 | 0 | 0 |
| Daniels et al.66 | 1,597 | NR | 28 | NR | ≥2.3 | 2.3 | ≥0.3 | ≥1.9 |
COVID-19, coronavirus disease 2019; LGE, late gadolinium enhancement; NR, not reported.